Neurodon Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $25M

  • Investors
  • 3

Neurodon General Information

Description

Developer of a therapeutic strategy designed to change the lives of patients suffering from debilitating diseases. The company's novel strategy focuses on halting the process of endoplasmic reticulum stress, which is a major cause of the disease, providing healthcare professionals with new technology and medicines that can effectively cure Parkinson's, Alzheimer's, and Huntington's disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • 9800 Conneticuit Drive
  • Crown Point, IN 46307
  • United States
+1 (219) 000-0000

Neurodon Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurodon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC $25M Upcoming Pre-Clinical Trials
8. Grant 23-Oct-2023 0000 00000 Completed Startup
7. Grant 03-Oct-2023 00000 00000 Completed Pre-Clinical Trials
6. Grant 12-Jul-2023 0000 00000 Completed Pre-Clinical Trials
5. Grant 12-Aug-2020 00.000 00000 Completed Pre-Clinical Trials
4. Angel (individual) 01-Jan-2020 00000 Completed Pre-Clinical Trials
3. Angel (individual) 17-Oct-2019 00000 00000 Completed Startup
2. Seed Round 04-Jan-2019 Completed Startup
1. Grant 24-Sep-2018 $225K Completed Startup
To view Neurodon’s complete valuation and funding history, request access »

Neurodon Patents

Neurodon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220016108-A1 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020 0000000000
EP-4037685-A4 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020 000000000
EP-4037685-A1 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020 000000000
CA-3186668-A1 Quinolines that modulate serca and their use for treating disease Pending 20-Jul-2020 000000000
US-11730729-B2 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020 A61K31/4706 00
To view Neurodon’s complete patent history, request access »

Neurodon Executive Team (1)

Name Title Board Seat Contact Info
Russell Dahl Ph.D Founder, Chief Executive Officer & Board Member
To view Neurodon’s complete executive team members history, request access »

Neurodon Board Members (2)

Name Representing Role Since
Brunde Broady Self Board Member & Advisor 000 0000
Russell Dahl Ph.D Neurodon Founder, Chief Executive Officer & Board Member 000 0000
To view Neurodon’s complete board members history, request access »

Neurodon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurodon Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Elevate Ventures Venture Capital Minority 000 0000 000000 0
The National Institute on Aging (NIA) Government 000 0000 000000 0
To view Neurodon’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »